| 000 | 01903 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250517093049.0 | ||
| 264 | 0 | _c20180116 | |
| 008 | 201801s 0 0 eng d | ||
| 022 | _a2160-7648 | ||
| 024 | 7 |
_a10.1002/cpdd.122 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKerbusch-Herben, Virginie | |
| 245 | 0 | 0 |
_aEffect of carbamazepine on the pharmacokinetics of paliperidone extended-release tablets at steady-state. _h[electronic resource] |
| 260 |
_bClinical pharmacology in drug development _c09 2014 |
||
| 300 |
_a371-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study | ||
| 650 | 0 | 4 |
_aATP Binding Cassette Transporter, Subfamily B _xmetabolism |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntimanic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAntipsychotic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aArea Under Curve |
| 650 | 0 | 4 |
_aBipolar Disorder _xblood |
| 650 | 0 | 4 | _aBulgaria |
| 650 | 0 | 4 |
_aCarbamazepine _xadministration & dosage |
| 650 | 0 | 4 | _aCroatia |
| 650 | 0 | 4 | _aDelayed-Action Preparations |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aDrug Compounding |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIntestinal Absorption _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMetabolic Clearance Rate |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPaliperidone Palmitate _xadministration & dosage |
| 650 | 0 | 4 |
_aRenal Elimination _xdrug effects |
| 650 | 0 | 4 |
_aSchizophrenia _xblood |
| 650 | 0 | 4 | _aSchizophrenic Psychology |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aCleton, Adriaan | |
| 700 | 1 | _aBerwaerts, Joris | |
| 700 | 1 | _aVandebosch, An | |
| 700 | 1 | _aRemmerie, Bart | |
| 773 | 0 |
_tClinical pharmacology in drug development _gvol. 3 _gno. 5 _gp. 371-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/cpdd.122 _zAvailable from publisher's website |
| 999 |
_c25972401 _d25972401 |
||